and progressive motor peripheral neuropathy. The mean age at onset is approximately 4.7 years, with oculomotor apraxia appearing a few years later. Diagnosis is based on molecular genetic analysis ...
Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback